Global Mesylate Safinamide Supply, Demand and Key Producers, 2026-2032
The global Mesylate Safinamide market size is expected to reach $ 1455 million by 2032, rising at a market growth of 15.0% CAGR during the forecast period (2026-2032).
In 2025, global safinamide mesylate tablet production reached approximately 321,700 units.Safinamide is a medication used to treat Parkinson's disease, primarily working by inhibiting monoamine oxidase B (MAO-B) and enhancing dopamine release. It helps regulate the dopamine system in the brain, alleviating motor symptoms in Parkinson's disease patients, such as tremors, rigidity, and bradykinesia. Safinamide is often used in combination with levodopa to enhance treatment efficacy, particularly when the effects of levodopa diminish. The medication is typically available in oral tablet form, and patients use it according to their doctor's guidance. During treatment, safinamide can significantly improve the patient's quality of life and reduce symptom fluctuations.
Safinamide holds an important position in the global Parkinson's disease treatment market, especially in improving motor symptoms in Parkinson's disease patients. With the aging population increasing, the number of Parkinson's disease patients globally continues to rise, providing a broad market demand for Safinamide. This drug works by inhibiting monoamine oxidase B (MAO-B) and enhancing dopamine release, alleviating symptoms in Parkinson's disease patients. When used in combination with levodopa, it significantly improves treatment outcomes and enhances the quality of life for patients. The market prospects for Safinamide are driven by several factors. Firstly, with the increase in early diagnosis of Parkinson's disease, the demand for effective medications among patients is growing. Secondly, Safinamide has strong competitiveness in the market, particularly among levodopa-resistant patient populations, where its use is gradually being recognized. However, there is still competition from other drugs such as dopamine agonists and anticholinergic medications, which results in a competitive market environment.
This report studies the global Mesylate Safinamide production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Mesylate Safinamide and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Mesylate Safinamide that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Mesylate Safinamide total production and demand, 2021-2032, (Units)
Global Mesylate Safinamide total production value, 2021-2032, (USD Million)
Global Mesylate Safinamide production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Mesylate Safinamide consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Mesylate Safinamide domestic production, consumption, key domestic manufacturers and share
Global Mesylate Safinamide production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Mesylate Safinamide production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Mesylate Safinamide production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Mesylate Safinamide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zambon S.p.A., Polpharma, Biophore India Pharmaceuticals Pvt Ltd, LGM Pharma, Metrochem API Private Limited, Cohance Lifesciences, Zhejiang Hengkang Pharmaceutical, HRV Pharma, Honour Lab Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Mesylate Safinamide market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Mesylate Safinamide Market, By Region:
1. How big is the global Mesylate Safinamide market?
2. What is the demand of the global Mesylate Safinamide market?
3. What is the year over year growth of the global Mesylate Safinamide market?
4. What is the production and production value of the global Mesylate Safinamide market?
5. Who are the key producers in the global Mesylate Safinamide market?
6. What are the growth factors driving the market demand?
In 2025, global safinamide mesylate tablet production reached approximately 321,700 units.Safinamide is a medication used to treat Parkinson's disease, primarily working by inhibiting monoamine oxidase B (MAO-B) and enhancing dopamine release. It helps regulate the dopamine system in the brain, alleviating motor symptoms in Parkinson's disease patients, such as tremors, rigidity, and bradykinesia. Safinamide is often used in combination with levodopa to enhance treatment efficacy, particularly when the effects of levodopa diminish. The medication is typically available in oral tablet form, and patients use it according to their doctor's guidance. During treatment, safinamide can significantly improve the patient's quality of life and reduce symptom fluctuations.
Safinamide holds an important position in the global Parkinson's disease treatment market, especially in improving motor symptoms in Parkinson's disease patients. With the aging population increasing, the number of Parkinson's disease patients globally continues to rise, providing a broad market demand for Safinamide. This drug works by inhibiting monoamine oxidase B (MAO-B) and enhancing dopamine release, alleviating symptoms in Parkinson's disease patients. When used in combination with levodopa, it significantly improves treatment outcomes and enhances the quality of life for patients. The market prospects for Safinamide are driven by several factors. Firstly, with the increase in early diagnosis of Parkinson's disease, the demand for effective medications among patients is growing. Secondly, Safinamide has strong competitiveness in the market, particularly among levodopa-resistant patient populations, where its use is gradually being recognized. However, there is still competition from other drugs such as dopamine agonists and anticholinergic medications, which results in a competitive market environment.
This report studies the global Mesylate Safinamide production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Mesylate Safinamide and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Mesylate Safinamide that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Mesylate Safinamide total production and demand, 2021-2032, (Units)
Global Mesylate Safinamide total production value, 2021-2032, (USD Million)
Global Mesylate Safinamide production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Mesylate Safinamide consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Mesylate Safinamide domestic production, consumption, key domestic manufacturers and share
Global Mesylate Safinamide production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Mesylate Safinamide production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Mesylate Safinamide production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Mesylate Safinamide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zambon S.p.A., Polpharma, Biophore India Pharmaceuticals Pvt Ltd, LGM Pharma, Metrochem API Private Limited, Cohance Lifesciences, Zhejiang Hengkang Pharmaceutical, HRV Pharma, Honour Lab Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Mesylate Safinamide market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Mesylate Safinamide Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Hospitals
- Retail
- Online
- Safinamide Mesylate in combination with Dopamine Receptor Agonists
- Safinamide Mesylate in combination with Levodopa
- Oral
- Injectable
- Innovator
- Generic
- Used in combination with Levodopa
- Treatment of Levodopa-resistant Parkinson's Disease
- Others
- Zambon S.p.A.
- Polpharma
- Biophore India Pharmaceuticals Pvt Ltd
- LGM Pharma
- Metrochem API Private Limited
- Cohance Lifesciences
- Zhejiang Hengkang Pharmaceutical
- HRV Pharma
- Honour Lab Limited
1. How big is the global Mesylate Safinamide market?
2. What is the demand of the global Mesylate Safinamide market?
3. What is the year over year growth of the global Mesylate Safinamide market?
4. What is the production and production value of the global Mesylate Safinamide market?
5. Who are the key producers in the global Mesylate Safinamide market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Mesylate Safinamide Introduction
1.2 World Mesylate Safinamide Supply & Forecast
1.2.1 World Mesylate Safinamide Production Value (2021 & 2025 & 2032)
1.2.2 World Mesylate Safinamide Production (2021-2032)
1.2.3 World Mesylate Safinamide Pricing Trends (2021-2032)
1.3 World Mesylate Safinamide Production by Region (Based on Production Site)
1.3.1 World Mesylate Safinamide Production Value by Region (2021-2032)
1.3.2 World Mesylate Safinamide Production by Region (2021-2032)
1.3.3 World Mesylate Safinamide Average Price by Region (2021-2032)
1.3.4 North America Mesylate Safinamide Production (2021-2032)
1.3.5 Europe Mesylate Safinamide Production (2021-2032)
1.3.6 China Mesylate Safinamide Production (2021-2032)
1.3.7 Japan Mesylate Safinamide Production (2021-2032)
1.3.8 India Mesylate Safinamide Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Mesylate Safinamide Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Mesylate Safinamide Major Market Trends
2 DEMAND SUMMARY
2.1 World Mesylate Safinamide Demand (2021-2032)
2.2 World Mesylate Safinamide Consumption by Region
2.2.1 World Mesylate Safinamide Consumption by Region (2021-2026)
2.2.2 World Mesylate Safinamide Consumption Forecast by Region (2027-2032)
2.3 United States Mesylate Safinamide Consumption (2021-2032)
2.4 China Mesylate Safinamide Consumption (2021-2032)
2.5 Europe Mesylate Safinamide Consumption (2021-2032)
2.6 Japan Mesylate Safinamide Consumption (2021-2032)
2.7 South Korea Mesylate Safinamide Consumption (2021-2032)
2.8 ASEAN Mesylate Safinamide Consumption (2021-2032)
2.9 India Mesylate Safinamide Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Mesylate Safinamide Production Value by Manufacturer (2021-2026)
3.2 World Mesylate Safinamide Production by Manufacturer (2021-2026)
3.3 World Mesylate Safinamide Average Price by Manufacturer (2021-2026)
3.4 Mesylate Safinamide Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Mesylate Safinamide Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Mesylate Safinamide in 2025
3.5.3 Global Concentration Ratios (CR8) for Mesylate Safinamide in 2025
3.6 Mesylate Safinamide Market: Overall Company Footprint Analysis
3.6.1 Mesylate Safinamide Market: Region Footprint
3.6.2 Mesylate Safinamide Market: Company Product Type Footprint
3.6.3 Mesylate Safinamide Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Mesylate Safinamide Production Value Comparison
4.1.1 United States VS China: Mesylate Safinamide Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Mesylate Safinamide Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Mesylate Safinamide Production Comparison
4.2.1 United States VS China: Mesylate Safinamide Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Mesylate Safinamide Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Mesylate Safinamide Consumption Comparison
4.3.1 United States VS China: Mesylate Safinamide Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Mesylate Safinamide Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Mesylate Safinamide Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Mesylate Safinamide Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Mesylate Safinamide Production Value (2021-2026)
4.4.3 United States Based Manufacturers Mesylate Safinamide Production (2021-2026)
4.5 China Based Mesylate Safinamide Manufacturers and Market Share
4.5.1 China Based Mesylate Safinamide Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Mesylate Safinamide Production Value (2021-2026)
4.5.3 China Based Manufacturers Mesylate Safinamide Production (2021-2026)
4.6 Rest of World Based Mesylate Safinamide Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Mesylate Safinamide Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Mesylate Safinamide Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Mesylate Safinamide Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Mesylate Safinamide Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Hospitals
5.2.2 Retail
5.2.3 Online
5.3 Market Segment by Type
5.3.1 World Mesylate Safinamide Production by Type (2021-2032)
5.3.2 World Mesylate Safinamide Production Value by Type (2021-2032)
5.3.3 World Mesylate Safinamide Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY COMBINATION THERAPY
6.1 World Mesylate Safinamide Market Size Overview by Combination Therapy: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Combination Therapy
6.2.1 Safinamide Mesylate in combination with Dopamine Receptor Agonists
6.2.2 Safinamide Mesylate in combination with Levodopa
6.3 Market Segment by Combination Therapy
6.3.1 World Mesylate Safinamide Production by Combination Therapy (2021-2032)
6.3.2 World Mesylate Safinamide Production Value by Combination Therapy (2021-2032)
6.3.3 World Mesylate Safinamide Average Price by Combination Therapy (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World Mesylate Safinamide Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Oral
7.2.2 Injectable
7.3 Market Segment by Dosage Form
7.3.1 World Mesylate Safinamide Production by Dosage Form (2021-2032)
7.3.2 World Mesylate Safinamide Production Value by Dosage Form (2021-2032)
7.3.3 World Mesylate Safinamide Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY MANUFACTURING TECHNOLOGY
8.1 World Mesylate Safinamide Market Size Overview by Manufacturing Technology: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Manufacturing Technology
8.2.1 Innovator
8.2.2 Generic
8.3 Market Segment by Manufacturing Technology
8.3.1 World Mesylate Safinamide Production by Manufacturing Technology (2021-2032)
8.3.2 World Mesylate Safinamide Production Value by Manufacturing Technology (2021-2032)
8.3.3 World Mesylate Safinamide Average Price by Manufacturing Technology (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Mesylate Safinamide Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Used in combination with Levodopa
9.2.2 Treatment of Levodopa-resistant Parkinson's Disease
9.2.3 Others
9.3 Market Segment by Application
9.3.1 World Mesylate Safinamide Production by Application (2021-2032)
9.3.2 World Mesylate Safinamide Production Value by Application (2021-2032)
9.3.3 World Mesylate Safinamide Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Zambon S.p.A.
10.1.1 Zambon S.p.A. Details
10.1.2 Zambon S.p.A. Major Business
10.1.3 Zambon S.p.A. Mesylate Safinamide Product and Services
10.1.4 Zambon S.p.A. Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Zambon S.p.A. Recent Developments/Updates
10.1.6 Zambon S.p.A. Competitive Strengths & Weaknesses
10.2 Polpharma
10.2.1 Polpharma Details
10.2.2 Polpharma Major Business
10.2.3 Polpharma Mesylate Safinamide Product and Services
10.2.4 Polpharma Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Polpharma Recent Developments/Updates
10.2.6 Polpharma Competitive Strengths & Weaknesses
10.3 Biophore India Pharmaceuticals Pvt Ltd
10.3.1 Biophore India Pharmaceuticals Pvt Ltd Details
10.3.2 Biophore India Pharmaceuticals Pvt Ltd Major Business
10.3.3 Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Product and Services
10.3.4 Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Biophore India Pharmaceuticals Pvt Ltd Recent Developments/Updates
10.3.6 Biophore India Pharmaceuticals Pvt Ltd Competitive Strengths & Weaknesses
10.4 LGM Pharma
10.4.1 LGM Pharma Details
10.4.2 LGM Pharma Major Business
10.4.3 LGM Pharma Mesylate Safinamide Product and Services
10.4.4 LGM Pharma Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 LGM Pharma Recent Developments/Updates
10.4.6 LGM Pharma Competitive Strengths & Weaknesses
10.5 Metrochem API Private Limited
10.5.1 Metrochem API Private Limited Details
10.5.2 Metrochem API Private Limited Major Business
10.5.3 Metrochem API Private Limited Mesylate Safinamide Product and Services
10.5.4 Metrochem API Private Limited Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Metrochem API Private Limited Recent Developments/Updates
10.5.6 Metrochem API Private Limited Competitive Strengths & Weaknesses
10.6 Cohance Lifesciences
10.6.1 Cohance Lifesciences Details
10.6.2 Cohance Lifesciences Major Business
10.6.3 Cohance Lifesciences Mesylate Safinamide Product and Services
10.6.4 Cohance Lifesciences Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Cohance Lifesciences Recent Developments/Updates
10.6.6 Cohance Lifesciences Competitive Strengths & Weaknesses
10.7 Zhejiang Hengkang Pharmaceutical
10.7.1 Zhejiang Hengkang Pharmaceutical Details
10.7.2 Zhejiang Hengkang Pharmaceutical Major Business
10.7.3 Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Product and Services
10.7.4 Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
10.7.6 Zhejiang Hengkang Pharmaceutical Competitive Strengths & Weaknesses
10.8 HRV Pharma
10.8.1 HRV Pharma Details
10.8.2 HRV Pharma Major Business
10.8.3 HRV Pharma Mesylate Safinamide Product and Services
10.8.4 HRV Pharma Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 HRV Pharma Recent Developments/Updates
10.8.6 HRV Pharma Competitive Strengths & Weaknesses
10.9 Honour Lab Limited
10.9.1 Honour Lab Limited Details
10.9.2 Honour Lab Limited Major Business
10.9.3 Honour Lab Limited Mesylate Safinamide Product and Services
10.9.4 Honour Lab Limited Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 Honour Lab Limited Recent Developments/Updates
10.9.6 Honour Lab Limited Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Mesylate Safinamide Industry Chain
11.2 Mesylate Safinamide Upstream Analysis
11.2.1 Mesylate Safinamide Core Raw Materials
11.2.2 Main Manufacturers of Mesylate Safinamide Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Mesylate Safinamide Production Mode
11.6 Mesylate Safinamide Procurement Model
11.7 Mesylate Safinamide Industry Sales Model and Sales Channels
11.7.1 Mesylate Safinamide Sales Model
11.7.2 Mesylate Safinamide Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Mesylate Safinamide Introduction
1.2 World Mesylate Safinamide Supply & Forecast
1.2.1 World Mesylate Safinamide Production Value (2021 & 2025 & 2032)
1.2.2 World Mesylate Safinamide Production (2021-2032)
1.2.3 World Mesylate Safinamide Pricing Trends (2021-2032)
1.3 World Mesylate Safinamide Production by Region (Based on Production Site)
1.3.1 World Mesylate Safinamide Production Value by Region (2021-2032)
1.3.2 World Mesylate Safinamide Production by Region (2021-2032)
1.3.3 World Mesylate Safinamide Average Price by Region (2021-2032)
1.3.4 North America Mesylate Safinamide Production (2021-2032)
1.3.5 Europe Mesylate Safinamide Production (2021-2032)
1.3.6 China Mesylate Safinamide Production (2021-2032)
1.3.7 Japan Mesylate Safinamide Production (2021-2032)
1.3.8 India Mesylate Safinamide Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Mesylate Safinamide Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Mesylate Safinamide Major Market Trends
2 DEMAND SUMMARY
2.1 World Mesylate Safinamide Demand (2021-2032)
2.2 World Mesylate Safinamide Consumption by Region
2.2.1 World Mesylate Safinamide Consumption by Region (2021-2026)
2.2.2 World Mesylate Safinamide Consumption Forecast by Region (2027-2032)
2.3 United States Mesylate Safinamide Consumption (2021-2032)
2.4 China Mesylate Safinamide Consumption (2021-2032)
2.5 Europe Mesylate Safinamide Consumption (2021-2032)
2.6 Japan Mesylate Safinamide Consumption (2021-2032)
2.7 South Korea Mesylate Safinamide Consumption (2021-2032)
2.8 ASEAN Mesylate Safinamide Consumption (2021-2032)
2.9 India Mesylate Safinamide Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Mesylate Safinamide Production Value by Manufacturer (2021-2026)
3.2 World Mesylate Safinamide Production by Manufacturer (2021-2026)
3.3 World Mesylate Safinamide Average Price by Manufacturer (2021-2026)
3.4 Mesylate Safinamide Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Mesylate Safinamide Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Mesylate Safinamide in 2025
3.5.3 Global Concentration Ratios (CR8) for Mesylate Safinamide in 2025
3.6 Mesylate Safinamide Market: Overall Company Footprint Analysis
3.6.1 Mesylate Safinamide Market: Region Footprint
3.6.2 Mesylate Safinamide Market: Company Product Type Footprint
3.6.3 Mesylate Safinamide Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Mesylate Safinamide Production Value Comparison
4.1.1 United States VS China: Mesylate Safinamide Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Mesylate Safinamide Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Mesylate Safinamide Production Comparison
4.2.1 United States VS China: Mesylate Safinamide Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Mesylate Safinamide Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Mesylate Safinamide Consumption Comparison
4.3.1 United States VS China: Mesylate Safinamide Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Mesylate Safinamide Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Mesylate Safinamide Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Mesylate Safinamide Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Mesylate Safinamide Production Value (2021-2026)
4.4.3 United States Based Manufacturers Mesylate Safinamide Production (2021-2026)
4.5 China Based Mesylate Safinamide Manufacturers and Market Share
4.5.1 China Based Mesylate Safinamide Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Mesylate Safinamide Production Value (2021-2026)
4.5.3 China Based Manufacturers Mesylate Safinamide Production (2021-2026)
4.6 Rest of World Based Mesylate Safinamide Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Mesylate Safinamide Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Mesylate Safinamide Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Mesylate Safinamide Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Mesylate Safinamide Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Hospitals
5.2.2 Retail
5.2.3 Online
5.3 Market Segment by Type
5.3.1 World Mesylate Safinamide Production by Type (2021-2032)
5.3.2 World Mesylate Safinamide Production Value by Type (2021-2032)
5.3.3 World Mesylate Safinamide Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY COMBINATION THERAPY
6.1 World Mesylate Safinamide Market Size Overview by Combination Therapy: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Combination Therapy
6.2.1 Safinamide Mesylate in combination with Dopamine Receptor Agonists
6.2.2 Safinamide Mesylate in combination with Levodopa
6.3 Market Segment by Combination Therapy
6.3.1 World Mesylate Safinamide Production by Combination Therapy (2021-2032)
6.3.2 World Mesylate Safinamide Production Value by Combination Therapy (2021-2032)
6.3.3 World Mesylate Safinamide Average Price by Combination Therapy (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World Mesylate Safinamide Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Oral
7.2.2 Injectable
7.3 Market Segment by Dosage Form
7.3.1 World Mesylate Safinamide Production by Dosage Form (2021-2032)
7.3.2 World Mesylate Safinamide Production Value by Dosage Form (2021-2032)
7.3.3 World Mesylate Safinamide Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY MANUFACTURING TECHNOLOGY
8.1 World Mesylate Safinamide Market Size Overview by Manufacturing Technology: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Manufacturing Technology
8.2.1 Innovator
8.2.2 Generic
8.3 Market Segment by Manufacturing Technology
8.3.1 World Mesylate Safinamide Production by Manufacturing Technology (2021-2032)
8.3.2 World Mesylate Safinamide Production Value by Manufacturing Technology (2021-2032)
8.3.3 World Mesylate Safinamide Average Price by Manufacturing Technology (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Mesylate Safinamide Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Used in combination with Levodopa
9.2.2 Treatment of Levodopa-resistant Parkinson's Disease
9.2.3 Others
9.3 Market Segment by Application
9.3.1 World Mesylate Safinamide Production by Application (2021-2032)
9.3.2 World Mesylate Safinamide Production Value by Application (2021-2032)
9.3.3 World Mesylate Safinamide Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Zambon S.p.A.
10.1.1 Zambon S.p.A. Details
10.1.2 Zambon S.p.A. Major Business
10.1.3 Zambon S.p.A. Mesylate Safinamide Product and Services
10.1.4 Zambon S.p.A. Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Zambon S.p.A. Recent Developments/Updates
10.1.6 Zambon S.p.A. Competitive Strengths & Weaknesses
10.2 Polpharma
10.2.1 Polpharma Details
10.2.2 Polpharma Major Business
10.2.3 Polpharma Mesylate Safinamide Product and Services
10.2.4 Polpharma Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Polpharma Recent Developments/Updates
10.2.6 Polpharma Competitive Strengths & Weaknesses
10.3 Biophore India Pharmaceuticals Pvt Ltd
10.3.1 Biophore India Pharmaceuticals Pvt Ltd Details
10.3.2 Biophore India Pharmaceuticals Pvt Ltd Major Business
10.3.3 Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Product and Services
10.3.4 Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Biophore India Pharmaceuticals Pvt Ltd Recent Developments/Updates
10.3.6 Biophore India Pharmaceuticals Pvt Ltd Competitive Strengths & Weaknesses
10.4 LGM Pharma
10.4.1 LGM Pharma Details
10.4.2 LGM Pharma Major Business
10.4.3 LGM Pharma Mesylate Safinamide Product and Services
10.4.4 LGM Pharma Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 LGM Pharma Recent Developments/Updates
10.4.6 LGM Pharma Competitive Strengths & Weaknesses
10.5 Metrochem API Private Limited
10.5.1 Metrochem API Private Limited Details
10.5.2 Metrochem API Private Limited Major Business
10.5.3 Metrochem API Private Limited Mesylate Safinamide Product and Services
10.5.4 Metrochem API Private Limited Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Metrochem API Private Limited Recent Developments/Updates
10.5.6 Metrochem API Private Limited Competitive Strengths & Weaknesses
10.6 Cohance Lifesciences
10.6.1 Cohance Lifesciences Details
10.6.2 Cohance Lifesciences Major Business
10.6.3 Cohance Lifesciences Mesylate Safinamide Product and Services
10.6.4 Cohance Lifesciences Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Cohance Lifesciences Recent Developments/Updates
10.6.6 Cohance Lifesciences Competitive Strengths & Weaknesses
10.7 Zhejiang Hengkang Pharmaceutical
10.7.1 Zhejiang Hengkang Pharmaceutical Details
10.7.2 Zhejiang Hengkang Pharmaceutical Major Business
10.7.3 Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Product and Services
10.7.4 Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
10.7.6 Zhejiang Hengkang Pharmaceutical Competitive Strengths & Weaknesses
10.8 HRV Pharma
10.8.1 HRV Pharma Details
10.8.2 HRV Pharma Major Business
10.8.3 HRV Pharma Mesylate Safinamide Product and Services
10.8.4 HRV Pharma Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 HRV Pharma Recent Developments/Updates
10.8.6 HRV Pharma Competitive Strengths & Weaknesses
10.9 Honour Lab Limited
10.9.1 Honour Lab Limited Details
10.9.2 Honour Lab Limited Major Business
10.9.3 Honour Lab Limited Mesylate Safinamide Product and Services
10.9.4 Honour Lab Limited Mesylate Safinamide Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 Honour Lab Limited Recent Developments/Updates
10.9.6 Honour Lab Limited Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Mesylate Safinamide Industry Chain
11.2 Mesylate Safinamide Upstream Analysis
11.2.1 Mesylate Safinamide Core Raw Materials
11.2.2 Main Manufacturers of Mesylate Safinamide Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Mesylate Safinamide Production Mode
11.6 Mesylate Safinamide Procurement Model
11.7 Mesylate Safinamide Industry Sales Model and Sales Channels
11.7.1 Mesylate Safinamide Sales Model
11.7.2 Mesylate Safinamide Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Mesylate Safinamide Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Mesylate Safinamide Production Value by Region (2021-2026) & (USD Million)
Table 3. World Mesylate Safinamide Production Value by Region (2027-2032) & (USD Million)
Table 4. World Mesylate Safinamide Production Value Market Share by Region (2021-2026)
Table 5. World Mesylate Safinamide Production Value Market Share by Region (2027-2032)
Table 6. World Mesylate Safinamide Production by Region (2021-2026) & (Units)
Table 7. World Mesylate Safinamide Production by Region (2027-2032) & (Units)
Table 8. World Mesylate Safinamide Production Market Share by Region (2021-2026)
Table 9. World Mesylate Safinamide Production Market Share by Region (2027-2032)
Table 10. World Mesylate Safinamide Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Mesylate Safinamide Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Mesylate Safinamide Major Market Trends
Table 13. World Mesylate Safinamide Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Mesylate Safinamide Consumption by Region (2021-2026) & (Units)
Table 15. World Mesylate Safinamide Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Mesylate Safinamide Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Mesylate Safinamide Producers in 2025
Table 18. World Mesylate Safinamide Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Mesylate Safinamide Producers in 2025
Table 20. World Mesylate Safinamide Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Mesylate Safinamide Company Evaluation Quadrant
Table 22. World Mesylate Safinamide Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Mesylate Safinamide Production Site of Key Manufacturer
Table 24. Mesylate Safinamide Market: Company Product Type Footprint
Table 25. Mesylate Safinamide Market: Company Product Application Footprint
Table 26. Mesylate Safinamide Competitive Factors
Table 27. Mesylate Safinamide New Entrant and Capacity Expansion Plans
Table 28. Mesylate Safinamide Mergers & Acquisitions Activity
Table 29. United States VS China Mesylate Safinamide Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Mesylate Safinamide Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Mesylate Safinamide Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Mesylate Safinamide Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Mesylate Safinamide Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Mesylate Safinamide Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Mesylate Safinamide Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Mesylate Safinamide Production Market Share (2021-2026)
Table 37. China Based Mesylate Safinamide Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Mesylate Safinamide Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Mesylate Safinamide Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Mesylate Safinamide Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Mesylate Safinamide Production Market Share (2021-2026)
Table 42. Rest of World Based Mesylate Safinamide Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Mesylate Safinamide Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Mesylate Safinamide Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Mesylate Safinamide Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Mesylate Safinamide Production Market Share (2021-2026)
Table 47. World Mesylate Safinamide Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Mesylate Safinamide Production by Type (2021-2026) & (Units)
Table 49. World Mesylate Safinamide Production by Type (2027-2032) & (Units)
Table 50. World Mesylate Safinamide Production Value by Type (2021-2026) & (USD Million)
Table 51. World Mesylate Safinamide Production Value by Type (2027-2032) & (USD Million)
Table 52. World Mesylate Safinamide Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Mesylate Safinamide Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Mesylate Safinamide Production Value by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Table 55. World Mesylate Safinamide Production by Combination Therapy (2021-2026) & (Units)
Table 56. World Mesylate Safinamide Production by Combination Therapy (2027-2032) & (Units)
Table 57. World Mesylate Safinamide Production Value by Combination Therapy (2021-2026) & (USD Million)
Table 58. World Mesylate Safinamide Production Value by Combination Therapy (2027-2032) & (USD Million)
Table 59. World Mesylate Safinamide Average Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 60. World Mesylate Safinamide Average Price by Combination Therapy (2027-2032) & (US$/Unit)
Table 61. World Mesylate Safinamide Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Mesylate Safinamide Production by Dosage Form (2021-2026) & (Units)
Table 63. World Mesylate Safinamide Production by Dosage Form (2027-2032) & (Units)
Table 64. World Mesylate Safinamide Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World Mesylate Safinamide Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World Mesylate Safinamide Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 67. World Mesylate Safinamide Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 68. World Mesylate Safinamide Production Value by Manufacturing Technology, (USD Million), 2021 & 2025 & 2032
Table 69. World Mesylate Safinamide Production by Manufacturing Technology (2021-2026) & (Units)
Table 70. World Mesylate Safinamide Production by Manufacturing Technology (2027-2032) & (Units)
Table 71. World Mesylate Safinamide Production Value by Manufacturing Technology (2021-2026) & (USD Million)
Table 72. World Mesylate Safinamide Production Value by Manufacturing Technology (2027-2032) & (USD Million)
Table 73. World Mesylate Safinamide Average Price by Manufacturing Technology (2021-2026) & (US$/Unit)
Table 74. World Mesylate Safinamide Average Price by Manufacturing Technology (2027-2032) & (US$/Unit)
Table 75. World Mesylate Safinamide Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Mesylate Safinamide Production by Application (2021-2026) & (Units)
Table 77. World Mesylate Safinamide Production by Application (2027-2032) & (Units)
Table 78. World Mesylate Safinamide Production Value by Application (2021-2026) & (USD Million)
Table 79. World Mesylate Safinamide Production Value by Application (2027-2032) & (USD Million)
Table 80. World Mesylate Safinamide Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Mesylate Safinamide Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Zambon S.p.A. Basic Information, Manufacturing Base and Competitors
Table 83. Zambon S.p.A. Major Business
Table 84. Zambon S.p.A. Mesylate Safinamide Product and Services
Table 85. Zambon S.p.A. Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Zambon S.p.A. Recent Developments/Updates
Table 87. Zambon S.p.A. Competitive Strengths & Weaknesses
Table 88. Polpharma Basic Information, Manufacturing Base and Competitors
Table 89. Polpharma Major Business
Table 90. Polpharma Mesylate Safinamide Product and Services
Table 91. Polpharma Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Polpharma Recent Developments/Updates
Table 93. Polpharma Competitive Strengths & Weaknesses
Table 94. Biophore India Pharmaceuticals Pvt Ltd Basic Information, Manufacturing Base and Competitors
Table 95. Biophore India Pharmaceuticals Pvt Ltd Major Business
Table 96. Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Product and Services
Table 97. Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Biophore India Pharmaceuticals Pvt Ltd Recent Developments/Updates
Table 99. Biophore India Pharmaceuticals Pvt Ltd Competitive Strengths & Weaknesses
Table 100. LGM Pharma Basic Information, Manufacturing Base and Competitors
Table 101. LGM Pharma Major Business
Table 102. LGM Pharma Mesylate Safinamide Product and Services
Table 103. LGM Pharma Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. LGM Pharma Recent Developments/Updates
Table 105. LGM Pharma Competitive Strengths & Weaknesses
Table 106. Metrochem API Private Limited Basic Information, Manufacturing Base and Competitors
Table 107. Metrochem API Private Limited Major Business
Table 108. Metrochem API Private Limited Mesylate Safinamide Product and Services
Table 109. Metrochem API Private Limited Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Metrochem API Private Limited Recent Developments/Updates
Table 111. Metrochem API Private Limited Competitive Strengths & Weaknesses
Table 112. Cohance Lifesciences Basic Information, Manufacturing Base and Competitors
Table 113. Cohance Lifesciences Major Business
Table 114. Cohance Lifesciences Mesylate Safinamide Product and Services
Table 115. Cohance Lifesciences Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Cohance Lifesciences Recent Developments/Updates
Table 117. Cohance Lifesciences Competitive Strengths & Weaknesses
Table 118. Zhejiang Hengkang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 119. Zhejiang Hengkang Pharmaceutical Major Business
Table 120. Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Product and Services
Table 121. Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
Table 123. Zhejiang Hengkang Pharmaceutical Competitive Strengths & Weaknesses
Table 124. HRV Pharma Basic Information, Manufacturing Base and Competitors
Table 125. HRV Pharma Major Business
Table 126. HRV Pharma Mesylate Safinamide Product and Services
Table 127. HRV Pharma Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. HRV Pharma Recent Developments/Updates
Table 129. HRV Pharma Competitive Strengths & Weaknesses
Table 130. Honour Lab Limited Basic Information, Manufacturing Base and Competitors
Table 131. Honour Lab Limited Major Business
Table 132. Honour Lab Limited Mesylate Safinamide Product and Services
Table 133. Honour Lab Limited Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Honour Lab Limited Recent Developments/Updates
Table 135. Honour Lab Limited Competitive Strengths & Weaknesses
Table 136. Global Key Players of Mesylate Safinamide Upstream (Raw Materials)
Table 137. Global Mesylate Safinamide Typical Customers
Table 138. Mesylate Safinamide Typical Distributors
Table 1. World Mesylate Safinamide Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Mesylate Safinamide Production Value by Region (2021-2026) & (USD Million)
Table 3. World Mesylate Safinamide Production Value by Region (2027-2032) & (USD Million)
Table 4. World Mesylate Safinamide Production Value Market Share by Region (2021-2026)
Table 5. World Mesylate Safinamide Production Value Market Share by Region (2027-2032)
Table 6. World Mesylate Safinamide Production by Region (2021-2026) & (Units)
Table 7. World Mesylate Safinamide Production by Region (2027-2032) & (Units)
Table 8. World Mesylate Safinamide Production Market Share by Region (2021-2026)
Table 9. World Mesylate Safinamide Production Market Share by Region (2027-2032)
Table 10. World Mesylate Safinamide Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Mesylate Safinamide Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Mesylate Safinamide Major Market Trends
Table 13. World Mesylate Safinamide Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Mesylate Safinamide Consumption by Region (2021-2026) & (Units)
Table 15. World Mesylate Safinamide Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Mesylate Safinamide Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Mesylate Safinamide Producers in 2025
Table 18. World Mesylate Safinamide Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Mesylate Safinamide Producers in 2025
Table 20. World Mesylate Safinamide Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Mesylate Safinamide Company Evaluation Quadrant
Table 22. World Mesylate Safinamide Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Mesylate Safinamide Production Site of Key Manufacturer
Table 24. Mesylate Safinamide Market: Company Product Type Footprint
Table 25. Mesylate Safinamide Market: Company Product Application Footprint
Table 26. Mesylate Safinamide Competitive Factors
Table 27. Mesylate Safinamide New Entrant and Capacity Expansion Plans
Table 28. Mesylate Safinamide Mergers & Acquisitions Activity
Table 29. United States VS China Mesylate Safinamide Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Mesylate Safinamide Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Mesylate Safinamide Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Mesylate Safinamide Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Mesylate Safinamide Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Mesylate Safinamide Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Mesylate Safinamide Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Mesylate Safinamide Production Market Share (2021-2026)
Table 37. China Based Mesylate Safinamide Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Mesylate Safinamide Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Mesylate Safinamide Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Mesylate Safinamide Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Mesylate Safinamide Production Market Share (2021-2026)
Table 42. Rest of World Based Mesylate Safinamide Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Mesylate Safinamide Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Mesylate Safinamide Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Mesylate Safinamide Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Mesylate Safinamide Production Market Share (2021-2026)
Table 47. World Mesylate Safinamide Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Mesylate Safinamide Production by Type (2021-2026) & (Units)
Table 49. World Mesylate Safinamide Production by Type (2027-2032) & (Units)
Table 50. World Mesylate Safinamide Production Value by Type (2021-2026) & (USD Million)
Table 51. World Mesylate Safinamide Production Value by Type (2027-2032) & (USD Million)
Table 52. World Mesylate Safinamide Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Mesylate Safinamide Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Mesylate Safinamide Production Value by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Table 55. World Mesylate Safinamide Production by Combination Therapy (2021-2026) & (Units)
Table 56. World Mesylate Safinamide Production by Combination Therapy (2027-2032) & (Units)
Table 57. World Mesylate Safinamide Production Value by Combination Therapy (2021-2026) & (USD Million)
Table 58. World Mesylate Safinamide Production Value by Combination Therapy (2027-2032) & (USD Million)
Table 59. World Mesylate Safinamide Average Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 60. World Mesylate Safinamide Average Price by Combination Therapy (2027-2032) & (US$/Unit)
Table 61. World Mesylate Safinamide Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Mesylate Safinamide Production by Dosage Form (2021-2026) & (Units)
Table 63. World Mesylate Safinamide Production by Dosage Form (2027-2032) & (Units)
Table 64. World Mesylate Safinamide Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World Mesylate Safinamide Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World Mesylate Safinamide Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 67. World Mesylate Safinamide Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 68. World Mesylate Safinamide Production Value by Manufacturing Technology, (USD Million), 2021 & 2025 & 2032
Table 69. World Mesylate Safinamide Production by Manufacturing Technology (2021-2026) & (Units)
Table 70. World Mesylate Safinamide Production by Manufacturing Technology (2027-2032) & (Units)
Table 71. World Mesylate Safinamide Production Value by Manufacturing Technology (2021-2026) & (USD Million)
Table 72. World Mesylate Safinamide Production Value by Manufacturing Technology (2027-2032) & (USD Million)
Table 73. World Mesylate Safinamide Average Price by Manufacturing Technology (2021-2026) & (US$/Unit)
Table 74. World Mesylate Safinamide Average Price by Manufacturing Technology (2027-2032) & (US$/Unit)
Table 75. World Mesylate Safinamide Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Mesylate Safinamide Production by Application (2021-2026) & (Units)
Table 77. World Mesylate Safinamide Production by Application (2027-2032) & (Units)
Table 78. World Mesylate Safinamide Production Value by Application (2021-2026) & (USD Million)
Table 79. World Mesylate Safinamide Production Value by Application (2027-2032) & (USD Million)
Table 80. World Mesylate Safinamide Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Mesylate Safinamide Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Zambon S.p.A. Basic Information, Manufacturing Base and Competitors
Table 83. Zambon S.p.A. Major Business
Table 84. Zambon S.p.A. Mesylate Safinamide Product and Services
Table 85. Zambon S.p.A. Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Zambon S.p.A. Recent Developments/Updates
Table 87. Zambon S.p.A. Competitive Strengths & Weaknesses
Table 88. Polpharma Basic Information, Manufacturing Base and Competitors
Table 89. Polpharma Major Business
Table 90. Polpharma Mesylate Safinamide Product and Services
Table 91. Polpharma Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Polpharma Recent Developments/Updates
Table 93. Polpharma Competitive Strengths & Weaknesses
Table 94. Biophore India Pharmaceuticals Pvt Ltd Basic Information, Manufacturing Base and Competitors
Table 95. Biophore India Pharmaceuticals Pvt Ltd Major Business
Table 96. Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Product and Services
Table 97. Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Biophore India Pharmaceuticals Pvt Ltd Recent Developments/Updates
Table 99. Biophore India Pharmaceuticals Pvt Ltd Competitive Strengths & Weaknesses
Table 100. LGM Pharma Basic Information, Manufacturing Base and Competitors
Table 101. LGM Pharma Major Business
Table 102. LGM Pharma Mesylate Safinamide Product and Services
Table 103. LGM Pharma Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. LGM Pharma Recent Developments/Updates
Table 105. LGM Pharma Competitive Strengths & Weaknesses
Table 106. Metrochem API Private Limited Basic Information, Manufacturing Base and Competitors
Table 107. Metrochem API Private Limited Major Business
Table 108. Metrochem API Private Limited Mesylate Safinamide Product and Services
Table 109. Metrochem API Private Limited Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Metrochem API Private Limited Recent Developments/Updates
Table 111. Metrochem API Private Limited Competitive Strengths & Weaknesses
Table 112. Cohance Lifesciences Basic Information, Manufacturing Base and Competitors
Table 113. Cohance Lifesciences Major Business
Table 114. Cohance Lifesciences Mesylate Safinamide Product and Services
Table 115. Cohance Lifesciences Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Cohance Lifesciences Recent Developments/Updates
Table 117. Cohance Lifesciences Competitive Strengths & Weaknesses
Table 118. Zhejiang Hengkang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 119. Zhejiang Hengkang Pharmaceutical Major Business
Table 120. Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Product and Services
Table 121. Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
Table 123. Zhejiang Hengkang Pharmaceutical Competitive Strengths & Weaknesses
Table 124. HRV Pharma Basic Information, Manufacturing Base and Competitors
Table 125. HRV Pharma Major Business
Table 126. HRV Pharma Mesylate Safinamide Product and Services
Table 127. HRV Pharma Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. HRV Pharma Recent Developments/Updates
Table 129. HRV Pharma Competitive Strengths & Weaknesses
Table 130. Honour Lab Limited Basic Information, Manufacturing Base and Competitors
Table 131. Honour Lab Limited Major Business
Table 132. Honour Lab Limited Mesylate Safinamide Product and Services
Table 133. Honour Lab Limited Mesylate Safinamide Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Honour Lab Limited Recent Developments/Updates
Table 135. Honour Lab Limited Competitive Strengths & Weaknesses
Table 136. Global Key Players of Mesylate Safinamide Upstream (Raw Materials)
Table 137. Global Mesylate Safinamide Typical Customers
Table 138. Mesylate Safinamide Typical Distributors
LIST OF FIGURES
Figure 1. Mesylate Safinamide Picture
Figure 2. World Mesylate Safinamide Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Mesylate Safinamide Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Mesylate Safinamide Production (2021-2032) & (Units)
Figure 5. World Mesylate Safinamide Average Price (2021-2032) & (US$/Unit)
Figure 6. World Mesylate Safinamide Production Value Market Share by Region (2021-2032)
Figure 7. World Mesylate Safinamide Production Market Share by Region (2021-2032)
Figure 8. North America Mesylate Safinamide Production (2021-2032) & (Units)
Figure 9. Europe Mesylate Safinamide Production (2021-2032) & (Units)
Figure 10. China Mesylate Safinamide Production (2021-2032) & (Units)
Figure 11. Japan Mesylate Safinamide Production (2021-2032) & (Units)
Figure 12. India Mesylate Safinamide Production (2021-2032) & (Units)
Figure 13. Mesylate Safinamide Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 16. World Mesylate Safinamide Consumption Market Share by Region (2021-2032)
Figure 17. United States Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 18. China Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 19. Europe Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 20. Japan Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 21. South Korea Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 22. ASEAN Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 23. India Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Mesylate Safinamide by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Mesylate Safinamide Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Mesylate Safinamide Markets in 2025
Figure 27. United States VS China: Mesylate Safinamide Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Mesylate Safinamide Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Mesylate Safinamide Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Mesylate Safinamide Production Market Share 2025
Figure 31. China Based Manufacturers Mesylate Safinamide Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Mesylate Safinamide Production Market Share 2025
Figure 33. World Mesylate Safinamide Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Mesylate Safinamide Production Value Market Share by Type in 2025
Figure 35. Hospitals
Figure 36. Retail
Figure 37. Online
Figure 38. World Mesylate Safinamide Production Market Share by Type (2021-2032)
Figure 39. World Mesylate Safinamide Production Value Market Share by Type (2021-2032)
Figure 40. World Mesylate Safinamide Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. World Mesylate Safinamide Production Value by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Figure 42. World Mesylate Safinamide Production Value Market Share by Combination Therapy in 2025
Figure 43. Safinamide Mesylate in combination with Dopamine Receptor Agonists
Figure 44. Safinamide Mesylate in combination with Levodopa
Figure 45. World Mesylate Safinamide Production Market Share by Combination Therapy (2021-2032)
Figure 46. World Mesylate Safinamide Production Value Market Share by Combination Therapy (2021-2032)
Figure 47. World Mesylate Safinamide Average Price by Combination Therapy (2021-2032) & (US$/Unit)
Figure 48. World Mesylate Safinamide Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 49. World Mesylate Safinamide Production Value Market Share by Dosage Form in 2025
Figure 50. Oral
Figure 51. Injectable
Figure 52. World Mesylate Safinamide Production Market Share by Dosage Form (2021-2032)
Figure 53. World Mesylate Safinamide Production Value Market Share by Dosage Form (2021-2032)
Figure 54. World Mesylate Safinamide Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 55. World Mesylate Safinamide Production Value by Manufacturing Technology, (USD Million), 2021 & 2025 & 2032
Figure 56. World Mesylate Safinamide Production Value Market Share by Manufacturing Technology in 2025
Figure 57. Innovator
Figure 58. Generic
Figure 59. World Mesylate Safinamide Production Market Share by Manufacturing Technology (2021-2032)
Figure 60. World Mesylate Safinamide Production Value Market Share by Manufacturing Technology (2021-2032)
Figure 61. World Mesylate Safinamide Average Price by Manufacturing Technology (2021-2032) & (US$/Unit)
Figure 62. World Mesylate Safinamide Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World Mesylate Safinamide Production Value Market Share by Application in 2025
Figure 64. Used in combination with Levodopa
Figure 65. Treatment of Levodopa-resistant Parkinson's Disease
Figure 66. Others
Figure 67. World Mesylate Safinamide Production Market Share by Application (2021-2032)
Figure 68. World Mesylate Safinamide Production Value Market Share by Application (2021-2032)
Figure 69. World Mesylate Safinamide Average Price by Application (2021-2032) & (US$/Unit)
Figure 70. Mesylate Safinamide Industry Chain
Figure 71. Mesylate Safinamide Procurement Model
Figure 72. Mesylate Safinamide Sales Model
Figure 73. Mesylate Safinamide Sales Channels, Direct Sales, and Distribution
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Mesylate Safinamide Picture
Figure 2. World Mesylate Safinamide Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Mesylate Safinamide Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Mesylate Safinamide Production (2021-2032) & (Units)
Figure 5. World Mesylate Safinamide Average Price (2021-2032) & (US$/Unit)
Figure 6. World Mesylate Safinamide Production Value Market Share by Region (2021-2032)
Figure 7. World Mesylate Safinamide Production Market Share by Region (2021-2032)
Figure 8. North America Mesylate Safinamide Production (2021-2032) & (Units)
Figure 9. Europe Mesylate Safinamide Production (2021-2032) & (Units)
Figure 10. China Mesylate Safinamide Production (2021-2032) & (Units)
Figure 11. Japan Mesylate Safinamide Production (2021-2032) & (Units)
Figure 12. India Mesylate Safinamide Production (2021-2032) & (Units)
Figure 13. Mesylate Safinamide Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 16. World Mesylate Safinamide Consumption Market Share by Region (2021-2032)
Figure 17. United States Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 18. China Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 19. Europe Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 20. Japan Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 21. South Korea Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 22. ASEAN Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 23. India Mesylate Safinamide Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Mesylate Safinamide by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Mesylate Safinamide Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Mesylate Safinamide Markets in 2025
Figure 27. United States VS China: Mesylate Safinamide Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Mesylate Safinamide Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Mesylate Safinamide Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Mesylate Safinamide Production Market Share 2025
Figure 31. China Based Manufacturers Mesylate Safinamide Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Mesylate Safinamide Production Market Share 2025
Figure 33. World Mesylate Safinamide Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Mesylate Safinamide Production Value Market Share by Type in 2025
Figure 35. Hospitals
Figure 36. Retail
Figure 37. Online
Figure 38. World Mesylate Safinamide Production Market Share by Type (2021-2032)
Figure 39. World Mesylate Safinamide Production Value Market Share by Type (2021-2032)
Figure 40. World Mesylate Safinamide Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. World Mesylate Safinamide Production Value by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Figure 42. World Mesylate Safinamide Production Value Market Share by Combination Therapy in 2025
Figure 43. Safinamide Mesylate in combination with Dopamine Receptor Agonists
Figure 44. Safinamide Mesylate in combination with Levodopa
Figure 45. World Mesylate Safinamide Production Market Share by Combination Therapy (2021-2032)
Figure 46. World Mesylate Safinamide Production Value Market Share by Combination Therapy (2021-2032)
Figure 47. World Mesylate Safinamide Average Price by Combination Therapy (2021-2032) & (US$/Unit)
Figure 48. World Mesylate Safinamide Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 49. World Mesylate Safinamide Production Value Market Share by Dosage Form in 2025
Figure 50. Oral
Figure 51. Injectable
Figure 52. World Mesylate Safinamide Production Market Share by Dosage Form (2021-2032)
Figure 53. World Mesylate Safinamide Production Value Market Share by Dosage Form (2021-2032)
Figure 54. World Mesylate Safinamide Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 55. World Mesylate Safinamide Production Value by Manufacturing Technology, (USD Million), 2021 & 2025 & 2032
Figure 56. World Mesylate Safinamide Production Value Market Share by Manufacturing Technology in 2025
Figure 57. Innovator
Figure 58. Generic
Figure 59. World Mesylate Safinamide Production Market Share by Manufacturing Technology (2021-2032)
Figure 60. World Mesylate Safinamide Production Value Market Share by Manufacturing Technology (2021-2032)
Figure 61. World Mesylate Safinamide Average Price by Manufacturing Technology (2021-2032) & (US$/Unit)
Figure 62. World Mesylate Safinamide Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World Mesylate Safinamide Production Value Market Share by Application in 2025
Figure 64. Used in combination with Levodopa
Figure 65. Treatment of Levodopa-resistant Parkinson's Disease
Figure 66. Others
Figure 67. World Mesylate Safinamide Production Market Share by Application (2021-2032)
Figure 68. World Mesylate Safinamide Production Value Market Share by Application (2021-2032)
Figure 69. World Mesylate Safinamide Average Price by Application (2021-2032) & (US$/Unit)
Figure 70. Mesylate Safinamide Industry Chain
Figure 71. Mesylate Safinamide Procurement Model
Figure 72. Mesylate Safinamide Sales Model
Figure 73. Mesylate Safinamide Sales Channels, Direct Sales, and Distribution
Figure 74. Methodology
Figure 75. Research Process and Data Source
